Gareth Gregory

View Scopus Profile

Research activity per year

If you made any changes in Pure these will be visible here soon.

Education/Academic qualification

Cancer Therapeutics, Doctor of Philosophy, University of Melbourne

Award Date: 27 May 2017

External positions

Clinical & Laboratory Haematologist, Monash Health

2013 → …

2 Finished
2 Not started
15 Active

Expanded umbilical cord blood cells for neuroprotection in extremely preterm infants
McDonald, C., Malhotra, A., Yawno, T., Paton, M. C. B., Penny, T., Miller, S., Jenkin, G., Hunt, R., Zhou, L., Fahey, M. & Gregory, G.
Department of Health and Aged Care (Australia)
1/02/23 → 31/01/27
Project: Research
A Phase 1/2 Open-label, Multicenter Study Evaluating the Safety and Pharmacokinetics of Escalating Doses of IGM-2323 in Subjects with Relapsed/Refractory Non-Hodgkin Lymphomas
Gregory, G.
7/07/22 → 30/04/23
Project: Research
PCNSL: Phase II study of pembrolizumab checkpoint blockade following chemoimmunotherapy for primary central nervous system lymphoma: BLOCK CNS Lymphoma
Gregory, G.
22/11/21 → 31/12/26
Project: Research
A phase 3, multicenter, randomized, double-blind, placebo-controlled trial comparing the efficacy and safety of tafasitamab plus lenalidomide in addition to R-CHOP versus R-CHOP in previously untreated, high-intermediate and high-risk patients with newly-diagnosed diffuse large B-cell lymphoma (DLBCL)
Gregory, G.
9/08/21 → 8/08/26
Project: Research
A Phase 1b/2, Open-Label Trial to Assess the Safety and Preliminary Efficacy of Epcoritamab in Combination with Other Agents in Subjects with B-cell Non-Hodgkin Lymphoma
Gregory, G.
3/06/21 → 2/06/26
Project: Research

31 Article
12 Letter
4 Poster
3 Meeting Abstract
More

Clinical illness with viable severe acute respiratory coronavirus virus 2 (SARS-CoV-2) virus presenting 72 days after infection in an immunocompromised patient
Hughes, C. M., Gregory, G. P., Pierce, A. B., Druce, J. D., Catton, M., Chong, B., Sherry, N. L., Graham, M., Chen, M., Salvaris, R., Eise, N., Lee, J. Y. H., McQuilten, Z., Crouch, S., Looker, C., Korman, T. M. & Stuart, R. L., 19 Jun 2022, In: Infection Control & Hospital Epidemiology. 43, 6, p. 820-822 3 p.
Research output: Contribution to journal › Letter › Other › peer-review

Open Access

1 Citation (Scopus)
Concomitant diagnosis of chronic myeloid leukaemia and myeloma
Looi, W., Zargari, A., Dun, K., Grigoriadis, G., Fedele, P., Gregory, G. P. & Low, M. S. Y., Jun 2022, In: Pathology. 54, 4, p. 493-495 3 p.
Research output: Contribution to journal › Letter › Other › peer-review

Open Access
Diagnosis and management of primary central nervous system lymphoma: a consensus practice statement from the Australasian Lymphoma Alliance
Keane, C., Hamad, N., Barraclough, A., Lee, Y. Y., Talaulikar, D., Ku, M., Wight, J., Tatarczuch, M., Swain, F. & Gregory, G. P., 2022, (Accepted/In press) In: Internal Medicine Journal. 9 p.
Research output: Contribution to journal › Article › Research › peer-review
Integrated clinical and genomic evaluation of guadecitabine (SGI-110) in peripheral T-cell lymphoma
Wong, J., Gruber, E., Maher, B., Waltham, M., Sabouri-Thompson, Z., Jong, I., Luong, Q., Levy, S., Kumar, B., Brasacchio, D., Jia, W., So, J., Skinner, H., Lewis, A., Hogg, S. J., Vervoort, S., DiCorleto, C., Uhe, M., Gamgee, J., Opat, S., & 8 othersGregory, G. P., Polekhina, G., Reynolds, J., Hawkes, E. A., Kailainathan, G., Gasiorowski, R., Kats, L. M. & Shortt, J., Jun 2022, In: Leukemia. 36, 6, p. 1654–1665 12 p.
Research output: Contribution to journal › Article › Research › peer-review

Open Access

1 Citation (Scopus)
Pembrolizumab plus dinaciclib in patients with hematologic malignancies: the phase 1b KEYNOTE-155 study
Gregory, G. P., Kumar, S., Wang, D., Mahadevan, D., Walker, P., Wagner-Johnston, N., Escobar, C., Bannerji, R., Bhutani, D., Chang, J., Hernandez-Ilizaliturri, F. J., Klein, A., Pagel, J. M., Rybka, W., Yee, A. J., Mohrbacher, A., Huang, M., Farooqui, M., Marinello, P. & Quach, H., 22 Feb 2022, In: Blood Advances. 6, 4, p. 1232-1242 11 p.
Research output: Contribution to journal › Article › Research › peer-review

Open Access

1 Citation (Scopus)

Albert Baikie Memorial Medal for best presentation by a new investigator at the HSANZ Annual Scientific Meeting
Gregory, Gareth (Recipient), 2014
Prize: Prize (including medals and awards)
Cancer Therapeutics CRC PhD Top Up Scholarship
Gregory, Gareth (Recipient), 2015
Prize: Competitive Fellowships
European Hematology Association Clinical Research Training in Hematology Fellowship
Gregory, Gareth (Recipient), 2017
Prize: Prize (including medals and awards)
Leukaemia Foundation PhD Scholarship
Gregory, Gareth (Recipient), 2013
Prize: Competitive Fellowships
NHMRC Medical Postgraduate Research Scholarship
Gregory, Gareth (Recipient), 2013
Prize: Competitive Fellowships

3 Contribution to conference
1 Professional association or peak discipline body

HSANZ Annual Scientific Meeting 2016
Gareth Gregory (Session chair)
2016
Activity: Participating in or organising an event types › Contribution to conference
High-grade NHL & Hodgkin Lymphoma Disease Group Committee Member of the Scientific Advisory Committee
Gareth Gregory (Member)
2015 → 2017
Activity: External Academic Engagement › Professional association or peak discipline body
HSANZ Annual Scientific Meeting
Gareth Gregory (Speaker)
21 Oct 2014
Activity: Participating in or organising an event types › Contribution to conference
HSANZ Annual Scientific Meeting 2012
Gareth Gregory (Speaker)
29 Oct 2012
Activity: Participating in or organising an event types › Contribution to conference

Gareth Gregory

Personal profile

Education/Academic qualification

External positions

Network

Dive into details

Expanded umbilical cord blood cells for neuroprotection in extremely preterm infants

A Phase 1/2 Open-label, Multicenter Study Evaluating the Safety and Pharmacokinetics of Escalating Doses of IGM-2323 in Subjects with Relapsed/Refractory Non-Hodgkin Lymphomas

PCNSL: Phase II study of pembrolizumab checkpoint blockade following chemoimmunotherapy for primary central nervous system lymphoma: BLOCK CNS Lymphoma

A Phase 1b/2, Open-Label Trial to Assess the Safety and Preliminary Efficacy of Epcoritamab in Combination with Other Agents in Subjects with B-cell Non-Hodgkin Lymphoma

Clinical illness with viable severe acute respiratory coronavirus virus 2 (SARS-CoV-2) virus presenting 72 days after infection in an immunocompromised patient

Concomitant diagnosis of chronic myeloid leukaemia and myeloma

Diagnosis and management of primary central nervous system lymphoma: a consensus practice statement from the Australasian Lymphoma Alliance

Integrated clinical and genomic evaluation of guadecitabine (SGI-110) in peripheral T-cell lymphoma

Pembrolizumab plus dinaciclib in patients with hematologic malignancies: the phase 1b KEYNOTE-155 study

Albert Baikie Memorial Medal for best presentation by a new investigator at the HSANZ Annual Scientific Meeting

Cancer Therapeutics CRC PhD Top Up Scholarship

European Hematology Association Clinical Research Training in Hematology Fellowship

Leukaemia Foundation PhD Scholarship

NHMRC Medical Postgraduate Research Scholarship

HSANZ Annual Scientific Meeting 2016

High-grade NHL & Hodgkin Lymphoma Disease Group Committee Member of the Scientific Advisory Committee

HSANZ Annual Scientific Meeting

HSANZ Annual Scientific Meeting 2012

Gareth Gregory

Personal profile

Education/Academic qualification

External positions

Network

Projects

Research output

Prizes

Activities